Afficher la notice abrégée

Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry

dc.rights.licenseopenen_US
dc.contributor.authorDERNER, Ondrej
dc.contributor.authorKRAMER, Anneke
dc.contributor.authorHRUSKOVA, Zdenka
dc.contributor.authorARICI, Mustafa
dc.contributor.authorCOLLART, Frederic
dc.contributor.authorFINNE, Patrik
dc.contributor.authorFUENTES SANCHEZ, Laura
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorHARAMBAT, Jerome
IDREF: 110567358
dc.contributor.authorHEMMELDER, Marc H.
dc.contributor.authorHOMMEL, Kristine
dc.contributor.authorKERSCHBAUM, Julia
dc.contributor.authorDE MEESTER, Johan
dc.contributor.authorPALSSON, Runolfur
dc.contributor.authorSEGELMARK, Marten
dc.contributor.authorSKRUNES, Rannveig
dc.contributor.authorTRAYNOR, Jamie P.
dc.contributor.authorZURRIAGA, Oscar
dc.contributor.authorMASSY, Ziad A.
dc.contributor.authorJAGER, Kitty J.
dc.contributor.authorSTEL, Vianda S.
dc.contributor.authorTESAR, Vladimir
dc.date.accessioned2022-01-13T10:49:50Z
dc.date.available2022-01-13T10:49:50Z
dc.date.issued2021-11-06
dc.identifier.issn0272-6386en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/124375
dc.description.abstractEnRATIONALE AND OBJECTIVE: There is a dearth of data characterizing patients requiring kidney replacement therapy (KRT) for kidney failure due to systemic lupus erythematosus (SLE) and their clinical outcomes. The aim of this study was to describe trends in incidence and prevalence of KRT among these patients as well as to compare their outcomes to patients treated with KRT for diseases other than SLE. STUDY DESIGN: Retrospective cohort study based on kidney registry data. SETTING & PARTICIPANTS: Patients recorded in 14 registries of patients receiving kidney replacement therapy that provided data to the European Renal Association (ERA) Registry between 1992 and 2016. PREDICTOR: SLE as cause of kidney failure. OUTCOMES: Incidence and prevalence of KRT, patient survival while receiving KRT, patient and graft survival after kidney transplantation, and specific causes of death. ANALYTICAL APPROACH: Kaplan-Meier methods and Cox regression models were fit to compare patient survival between the SLE and non-SLE groups, overall KRT, dialysis and patient and graft survival after kidney transplantation. RESULTS: In total, 1826 patients commenced KRT for kidney failure due to SLE, representing an incidence of 0.80 per million population (pmp) per year. The incidence remained stable during the study period (annual percent change=0.1 [95%CI: -0.6 ; 0.8]). Patient survival among patients with SLE receiving KRT was similar to survival within the comparator group (HR=1.11 [95%CI: 0.99-1.23]). After kidney transplantation, the risk of death was greater among patients with SLE than among patients within the comparator group (HR=1.25 [95%CI: 1.02-1.53]), while the risk of all-cause graft failure was similar (HR=1.09 [95%CI: 0.95-1.27]). Ten-year patient overall survival on KRT, and patient and graft survival after kidney transplantation improved over the study period (HR=0.71 [95%CI: 0.56-0.91], 0.43 [0.27-0.69] and 0.60 [0.43-0.84], respectively). Patients with SLE receiving KRT were significantly more likely to die from infections (24.8%) than patients in the comparator group (16.9%, p<0.001). LIMITATIONS: No data were available on extrarenal manifestations of SLE, drug treatments, comorbidities, kidney transplant characteristics, or relapses of SLE. CONCLUSION: The prognosis of patients with SLE receiving KRT has improved over time. Survival of patients with SLE requiring KRT was similar when compared to patients requiring KRT due to other causes of kidney failure. Survival following kidney transplantation was worse among patients with SLE.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subject.enSystemic lupus erythematosus
dc.subject.enLupus nephritis
dc.subject.enKidney failure
dc.subject.enKidney replacement therapy
dc.subject.enKidney transplantation
dc.subject.enIncidence
dc.subject.enPrevalence
dc.subject.enSurvival
dc.title.enIncidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry
dc.typeArticle de revueen_US
dc.identifier.doi10.1053/j.ajkd.2021.09.016en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed34752912en_US
bordeaux.journalAmerican Journal of Kidney Diseasesen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamLEHA_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03524485
hal.version1
hal.date.transferred2022-01-13T10:49:54Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=American%20Journal%20of%20Kidney%20Diseases&amp;rft.date=2021-11-06&amp;rft.eissn=0272-6386&amp;rft.issn=0272-6386&amp;rft.au=DERNER,%20Ondrej&amp;KRAMER,%20Anneke&amp;HRUSKOVA,%20Zdenka&amp;ARICI,%20Mustafa&amp;COLLART,%20Frederic&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Nom:
BPH_AJKD_2021_Derner.pdf
Taille:
992.9Ko
Format:
PDF
Voir/Ouvrir
Thumbnail
Nom:
license_rdf
Taille:
811octets
Format:
application/rdf+xml
Voir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée